Press releases | WebDisclosure

REGULATED PRESS RELEASE

published on 09/03/2024 at 07:00, 1 year 5 months ago

Trading update
Gimv reports positive platform portfolio return for Q1 2024-25, Net Asset Value per share grows to EUR 52. Continued growth expected

Gimv Financial Year Investment Portfolio Growth
REGULATED PRESS RELEASE

published on 09/03/2024 at 07:00, 1 year 5 months ago

Trading update
Gimv reports positive platform portfolio return with a growth in NAV per share for the first quarter of FY 2024-25. Strong deal activity and investments signal future growth potential

Gimv Investment Portfolio Growth NAV
PRESS RELEASE

published on 09/03/2024 at 07:00, 1 year 5 months ago

Helvetica Swiss Opportunity Fund shows strong first half of 2024 and lowers vacancy rate to 2.3 %
Helvetica Swiss Opportunity Fund achieves solid first half results with reduced vacancy rate and plans for merger with HSC Fund. Net income of CHF 4.5 million

Merger Net Income Vacancy Rate Helvetica Swiss Opportunity Fund
PRESS RELEASE

published on 09/03/2024 at 07:00, 1 year 5 months ago

Helvetica Swiss Opportunity Fund affiche un solide premier semestre 2024 et réduit le taux de vacance à 2.3 %
Le Helvetica Swiss Opportunity Fund affiche un solide premier semestre 2024 avec un taux de vacance réduit à 2.3%. Préparatifs de fusion avec l'Helvetica Swiss Commercial Fund en cours

Investissement Fusion Taux De Vacance Fonds Résultat Semestriel
PRESS RELEASE

published on 09/03/2024 at 07:00, 1 year 5 months ago

Valneva et Pfizer annoncent de nouvelles données positives de Phase 2 après une vaccination de rappel pour le candidat vaccin contre la maladie de Lyme
Valneva et Pfizer rapportent des données positives de Phase 2 pour le candidat vaccin contre la maladie de Lyme, montrant une forte réponse immunitaire post-vaccination de rappel

Valneva Phase 2 Maladie De Lyme Pfizer Vaccin
PRESS RELEASE

published on 09/03/2024 at 07:00, 1 year 5 months ago

Valneva and Pfizer Report Further Positive Phase 2 Booster Results for Lyme Disease Vaccine Candidate
Valneva and Pfizer announce positive Phase 2 booster results for Lyme disease vaccine candidate, VLA15-221, showing strong immune response and safety profile, advancing towards Phase 3 trials

Valneva Phase 2 Lyme Disease Vaccine Pfizer Immunogenicity
PRESS RELEASE

published on 09/03/2024 at 06:55, 1 year 5 months ago

Leclanché to Exhibit at World’s Leading Marine Trade Fair, SMM Hamburg
Leclanché to exhibit its Navius MRS-3 marine rack system at SMM Hamburg, showcasing safety, performance, and sustainability. Meet them at booth 336, hall 6

Energy Storage Leclanché Navius MRS-3 SMM Hamburg Marine Trade Fair
PRESS RELEASE

published on 09/03/2024 at 06:55, 1 year 5 months ago

Leclanché exposera au plus grand salon maritime du monde, SMM Hamburg
Leclanché exposera son système de rack marin de dernière génération au salon SMM Hamburg, mettant en avant sécurité et durabilité

Leclanché Durabilité SMM Hamburg Energie Marine Rack Marin
PRESS RELEASE

published on 09/03/2024 at 06:45, 1 year 5 months ago

Prismo Metals Acquires Data and Updates Model for Hot Breccia Copper Project in Arizona
Prismo Metals Inc. updates mineralization model for Hot Breccia project in Arizona with historic data from Bear Creek Mining Company, revealing new insights. Exploration program for 2024 planned with $3.0 million budget

Exploration Program Mineralization Model Arizona Hot Breccia Project Prismo Metals Inc.
PRESS RELEASE

published on 09/03/2024 at 06:45, 1 year 5 months ago

Tommy Maussin rejoint le comité Exécutif de CARBIOS en tant que Directeur Marketing pour développer mondialement la présence de CARBIOS auprès des marques
Tommy Maussin rejoint CARBIOS en tant que Directeur Marketing pour développer mondialement la présence des marques. CARBIOS, entreprise de biotechnologie, réinvente le cycle de vie des plastiques et textiles

Biotechnologie Plastiques CARBIOS Tommy Maussin Directeur Marketing

Published on 02/21/2026 at 00:45, 7 minutes ago

Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 22 minutes ago

Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:15, 1 hour 37 minutes ago

DigiPower X Announces Closing of Settlement
Published on 02/20/2026 at 23:00, 1 hour 52 minutes ago

Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 2 hours 35 minutes ago

Organto Foods Completes Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 02/20/2026 at 18:36, 6 hours 16 minutes ago

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 6 hours 21 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:23, 6 hours 29 minutes ago

POS-Transaction in Own Shares
Published on 02/20/2026 at 18:00, 6 hours 52 minutes ago

Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 6 hours 52 minutes ago

Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations

View all EQS

Published on 02/20/2026 at 19:29, 5 hours 23 minutes ago

SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 5 hours 23 minutes ago

SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 6 hours 52 minutes ago

TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 6 hours 52 minutes ago

TERACT - Résiliation du contrat de liquidité
Published on 02/20/2026 at 17:35, 7 hours 17 minutes ago

CHIFFRE D'AFFAIRES 2025

View all LES ECHOS COMFI WIRE

News